Blood Glucose Monitoring Devices - Global Strategic Business Report

Blood Glucose Monitoring Devices - Global Strategic Business Report

Global Industry Analysts, Date of Publication: Aug 2, 2013, 299 Pages
US$4,950.00
GIA-MCP3420

This report analyzes the worldwide markets for Blood Glucose Monitoring Devices in US$ Million by the following Product Segments: Blood Glucose Strips, Blood Glucose Meters, and Lancets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 94 companies including many key and niche players such as Abbott Diabetes Care, Inc., Arkray, Inc., Arkray USA, Inc., Bayer Healthcare, Bionime Corp., B. Braun Melsungen AG, DexCom Inc., LifeScan Inc. Medtronic, Nipro Diagnostics, Inc., Nova Biomedical Corporation, Roche Diagnostics Corp., and Terumo Europe NV. Market data and analytics are derived from primary and secondary research.


TABLE OF CONTENTS


 I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
      Study Reliability and Reporting Limitations  I-1
      Disclaimers   I-2
      Data Interpretation & Reporting Level        I-2
       Quantitative Techniques & Analytics         I-3
      Product Definitions and Scope of Study       I-3
       Blood Glucose Strips   I-3
       Blood Glucose Meters   I-3
       Lancets      I-4


 II. EXECUTIVE SUMMARY

  1. INDUSTRY OVERVIEW 
      A Prelude     II-1
       Table 1: Worldwide Prevalence of Diabetes  Mellitus by
       Region: 2012 & 2030 (includes  corresponding Graph/Chart)        II-1
      Growth Stimulants in a Nutshell    II-3
      Competitive Landscape   II-3
       Table 2: Leading Players in the World Blood Glucose Meters
       Market (2012): Market Share Breakdown  for Roche, LifeScan,
       Bayer, Abbott and Others  (includes corresponding
       Graph/Chart) II-4
      Recession in Retrospect and the Road Ahead   II-4

  2. MARKET TRENDS, ISSUES AND DRIVERS
      Increasing Prevalence of Diabetes Buoyed  by Burgeoning Ageing
       Populace     II-6
       Table 3: Global Population Statistics for  the 65+ Age Group:
       2012         II-6
       Targeted Screening of Ageing Population Vital  to Stem
        Diabetes Epidemic     II-7
      Rising Awareness and Need for Testing Propels  Market Growth      II-7
       Pre-Diabetes Testing   II-8
       Post-Prandial Glucose Level Monitoring      II-8
      Online Marketing Increases Market Competition II-8
      Government Efforts to Curb Healthcare Expenditure  on Diabetes
       Care         II-9
      Self-Monitoring of Blood Glucose (SMBG) Remains  a Viable Option  II-9
       Rising Significance of Remote Blood Glucose  Monitoring II-10
      Rising Incidence and Undiagnosed Population  in Developing
       Countries Offer Significant  Growth Opportunities      II-10
       China: An Untapped Goldmine for Blood Glucose  Monitoring
        Devices     II-11
       Diabetic Epidemic Spurs Indian Market for Blood  Glucose
        Monitoring  II-11
      After PDAs, SMBG Makers Turn to Mobile Devices  to Woo Users
       On the Move  II-12
       Mobile Phone Penetration: An Opportunity Indicator  for
        Mobile-Based BGM Devices         II-12
        Table 4: Top Ten Countries by Number of  Mobile Users (2012)
        (includes corresponding Graph/Chart)       II-13
      Technological Innovations in the Blood Glucose  Monitoring
       Market: Spearheading Growth       II-14
       Artificial Pancreas Technology: A Potential Game  Changer for
        BGM Market  II-15
       Demand for Convenience Drives Development of  Non-Invasive
        BGM Devices II-16
        Research & Development Initiatives  in Non-Invasive Glucose
         Monitors   II-17
        Select Ocular Glucose Monitors under  Development     II-18
       Diasensor 1000: The World’s First Non-Invasive  Glucose Sensor   II-18
       Ultrasound Device Under Development to Monitor  Glucose Levels   II-18
       Real World Challenges Facing Non-Invasive &  Painless BGM        II-18
       Manufacturers Step up Focus on Multi-Featured  Blood Glucose
        Monitors    II-19
       CGM Technology: The New Torch-bearer for  the BGM Devices Market II-19
        Continuous Glucose Monitor (CGM) Vs  Conventional Blood
         Glucose Monitor (BGM)II-20
        Medtronics Dominates the Global CGM Devices Market    II-21
        Challenges Faced by the CGMS Market        II-22

  3. DIABETES - A MACRO PERSPECTIVE
      Diabetes in Adults: A Leading Killer in Developed  and
       Developing Nations     II-23
       Diabetes in Children and Young People       II-23
      What is Diabetes?       II-23
       Types of Diabetes      II-24
        Type I Diabetes: Insulin-Dependent Diabetes  Mellitus (IDDM)    II-24
        Type II Diabetes: Non-Insulin Dependent  Diabetes Mellitus
         (NIDDM)    II-25
         NIDDM: Higher Risk of Cardiovascular Disease         II-25
        Gestational Diabetes  II-26
        Impaired Fasting Glycaemia (IFG) & Impaired  Glucose
         Tolerance (IGT)      II-26
         Table 5: Prevalence of Diabetes Mellitus in  North America
         (2012 & 2030): Breakdown by  Country and Age Group (In 000
         People & %)  (includes corresponding Graph/Chart)    II-26

         Table 6: Prevalence of Diabetes Mellitus in  Europe (2012 &
         2030): Breakdown by Country  and Age Group (In 000 People &
         %)         II-27

         Table 7: Prevalence of Diabetes Mellitus in  South East
         Asia (2012 & 2030): Breakdown by  Country and Age Group (In
         000 People & %)  (includes corresponding Graph/Chart)II-28

         Table 8: Prevalence of Diabetes Mellitus in  Western Asia,
         Pacific Regions (2012 & 2030): Breakdown by Country and Age
         Group  (In 000 People & %)      II-29

         Table 9: Prevalence of Diabetes Mellitus in  South &
         Central America (2012 & 2030):  Breakdown by Country and
         Age Group  (In 000 People & %)  II-30

         Table 10: Prevalence of Diabetes Mellitus in  Africa (2012 &
         2030): Breakdown by Country  and Age Group (In 000 People & %)
        (includes corresponding Graph/Chart)       II-31

         Table 11: Prevalence of Diabetes Mellitus in  Middle East &
         North Africa (2012 & 2030):  Breakdown by Country and Age
         Group  (In 000 People & %)      II-32

  4. PRODUCT OVERVIEW
      Blood Glucose MonitoringII-33
      Blood Glucose Monitoring Devices   II-33
       Blood Glucose Meters   II-34
        Blood Glucose Monitoring Meters: A Historical  Perspective      II-34
        Types of Blood Glucose Meters    II-34
         All-In-One Blood Glucose Meters II-34
         Combined Wrist Blood Pressure and  Blood Glucose Meters        II-34
         Wrist-Watch Glucose Meters      II-35
         BGMs with In-Built Food Monitoring FeatureII-35
         Continuous Blood Glucose Meters II-35
         Talking Blood Glucose Meters    II-35
         Painless Blood Glucose Meters   II-36
         Multisite Blood Glucose Meters  II-36
         Plasma Blood Glucose Meters     II-36
        Measurement Units     II-36
        A Review of Select Blood Glucose Meters  in the MarketII-36
        A Review of Select Invasive Blood  Glucose Meters     II-38
        Various Continuous Blood Glucose Monitoring  Devices:
         Product Details & Status        II-38
       Blood Glucose Strips   II-40
       Lancets      II-40

  5. PRODUCT INNOVATIONS/INTRODUCTIONS
      Omron Unveils Advanced Blood Glucose MonitorsII-41
      ARKRAY USA Announces Compatibility of  GLUCOCARD® Blood
       Glucose Meters  with Glooko Mobile App      II-41
      Bayer HealthCare Pharmaceuticals Unveils  XT Glucometer and
       NEXT Test strips  under CONTOUR® Brand      II-41
      GE Healthcare and Bionime Introduce GE100 Blood  Glucose
       Monitoring System      II-42
      Nova Biomedical Unveils Nova Max™ Blood Glucose  Monitoring
       System       II-42
      BEURER Launches Three-in-one Blood  Glucose Monitor     II-42
      Bayer Diabetes Care to Launch Glucometer     II-42
      Cambridge Consultants Design Eco-friendly  Blood Glucose Monitor  II-42
      ARKRAY Unveils Audio-Enabled Blood Glucose  Monitoring System     II-43
      Sanofi Introduces iBGStar iPhone Blood Glucose  Meter in
       Various Countries      II-43
      Abbott Introduces FreeStyle InsuLinx in CanadaII-43
      Eidia to Introduce LIFE CHECK      II-44
      Telcare Displays Cellular Blood Glucose  Meter at AADE  II-44
      Sanofi Introduces BGSTAR® and IBGSTAR® Blood  Glucose Meters
       in France and Germany  II-44
      LifeScan Introduces ONETOUCH® SelectSimple™  II-45
      Telcare Integrates Blood Glucose Monitoring  with Wireless
       Connectivity II-45
      Sensa Core Introduces Gluco Spark Advanced  Glucose Monitoring
       System       II-45
      Bayer Launches DIDGET™ Blood Glucose Meter for  Diabetic Children II-46
      Abbott Diabetes Care Introduces Precision Xtra™  Biosensor
       Blood Glucose Test StripII-46
      Infopia America Introduces SmartDiabetes  Product Range II-46
      Fujitsu Launches Mobile Phone Service for  Diabetic Patients      II-47
      ACON Introduces On Call® Resolve Blood Glucose  Monitoring System II-47
      QuickMedical® Releases New BGM System        II-47
      Horizon MedCorp Offers New Resupply Program  II-48
      Nova Biomedical Provides Wireless Solution  for Glucose and
       Creatinine Meters      II-48
      Roche Diagnostic Introduces Accu-Chek(R) Glucose  Monitoring
       Device       II-48
      Qualcomm and Telcare to Introduce Mobile Health  Monitoring
       Device       II-49
      Artificial Life Rolls Out GluCoMO  II-49
      LifeScan Introduces OneTouch Delica Lancing System      II-49
      Pepex™ Releases Multi-Functional Blood  Glucose Meter   II-49
      Mendor to Unveil Discreet Meter    II-50
      ARKRAY Releases the Assure® Blood Glucose  Monitoring System      II-50
      Arkray Launches Ark Care™ System   II-50
      Medtronic Introduces CareLink® Pro 3.0 Therapy  Management
       Software for Diabetes  II-51
      Abbott Launches FreeStyle Lite® Test Strips  for Blood Glucose
       in Australian Market   II-51
      LifeScan to Introduce One Touch® Verio™  Glucose MonitorII-51
      Medtronic to Unveil iPro2 Professional CGM   II-52
      Nokia Unveils MyGlucoHealth Diabetes SoftwareII-52
      Bayer Launches Blood Glucose  Meter: CONTOUR® USB       II-52
      LifeScan Introduces One Touch “Verio” Glucose  Monitor  II-52
      Biocon Introduces Breeze-2 Blood Glucose Meters         II-53
      We Carewell Biotech Launches Eukare  Bio-Sensored Glucometer      II-53

  6. RECENT INDUSTRY ACTIVITY
      Abbott Recalls FreeStyle InsuLinx® BGMS      II-54
      LifeScan Initiates Recall and Replacement of  OneTouch® Verio
       ®IQ BGMs     II-54
      Lifescan Obtains FDA Approval for OneTouch  VerioSync   II-54
      Telcare BGM® Receives Clearance to Operate  on Verizon Network    II-55
      GE Healthcare Signs Licensing Agreement  with Bionime   II-55
      Modz Inks Agreement with Novo Nordisk        II-56
      Merck Serono Inks Distribution Deal with Mendor         II-56
      Abbott Renews Non-Exclusive Agreement  with INSULET     II-56
      Pepex Biomedical Inks Manufacturing Agreement  with Tech Group    II-56
      Pharmaco Bags Exclusive Distribution Rights  for CareSens
       Blood Glucose Meters   II-57
      Roche Obtains FDA Approval for ACCU-CHEK  Inform II System        II-57
      Dexcom Obtains USFDA Approval and CE Mark for  Dexcom G4™
       PLATINUM CGMSII-58
      Abbott Obtains FDA Approval for FreeStyle  InsuLinx BGM System    II-58
      StatStrip™ Glucose Monitor from Nova Receives  FDA Approval
       for Neonatal Testing   II-58
      Philosys Obtains CE Mark for its Gmate®  SMART BGMS     II-59
      Roche Obtains FDA Approval for Accu-Chek  Combo System  II-59
      ConnectedHealth Inks Agreements with  Nonin Medical, Entra and
       A&D Medical  II-59
      ARKRAY USA Secures Continuum of Care Contract  from Premier       II-60
      Entra Health Obtains Approval from TPD for  MyGlucoHealth
       Wireless Meter         II-60
      LifeScan Terminates Supply Agreement with  Medtronic MiniMed      II-60
      Telcare Obtains FDA 510(k) Clearance for 3G BGM         II-60
      SANOFI Obtains FDA 510(k) Clearance for  Its iBGSTAR™ BGMS        II-61
      Bayer Receives FDA Approval for Contour Next EZ         II-61
      Medtronic Obtains FDA Approval for iPro®2 CGMII-61
      Medtronic Commences Investigational Device  Exemption Study of
       Enlite™ Sensor         II-62
      Medtronic Partners with Ford to Develop Automotive  Glucose
       Monitor      II-62
      Animas and LifeScan Co-Develop Wireless  Insulin Pump   II-62
      Abbott Receives CE Mark for New Blood Glucose  Monitoring System  II-63
      Insulet Takes Over Neighborhood Diabetes     II-63
      Perrigo and AgaMatrix Ink Exclusive Distribution  and Sales Deal  II-63
      Biosign Technologies Revises Agreement with  DynamiCARE II-64
      KarmelSonix and OMRON Healthcare Enter  into Distribution Deal    II-64
      Freescale Semiconductor Enters into an Exclusive  Partnership
       with Cactus Semiconductor         II-64
      Accu-Chek® Enters into an Alliance with  Novo Nordisk   II-65
      Bayer HealthCare and Medtronic Expand Partnership       II-65
      PositiveID Announces Partnership with  HMD BioMedical to
       Produce iGlucometer    II-65
      Japanese Branch of Sanofi-Aventis to Sell AgaMatrix's  Blood
       Glucose Meters         II-65
      Zyxel and Entra Health Systems Ink Agreement II-66
      Panasonic to Manufacture Blood Sugar Meters  at New Facility      II-66
      Roche Diabetes and ICW to Co-develop Diabetes  Management System  II-66
      Animas Obtains Approval for Feature Enhancement  on OneTouch®
       Ping®        II-67
      PTPA Approves Bionime's Blood-Glucose Meters II-67
      Bayer Inks Strategic Partnership with Biocon II-67
      Novation Confers Agreement to Roche Diagnostics         II-67
      Nipro Corporation Acquires Home Diagnostics  II-68
      AgaMatrix Enters into Agreement with Sanofi-Aventis     II-68
      AmbiCom Holdings Bags WL54-CF Wi-Fi Card  Purchase OrderII-68
      Abbot Obtains FDA 510(k) Clearance for  FreeStyle® Test Strips    II-68

  7. FOCUS ON SELECT GLOBAL PLAYERS
      Abbott Diabetes Care, Inc. (US)    II-69
      Arkray, Inc. (Japan)    II-69
       Arkray USA, Inc. (US)  II-69
      Bayer Healthcare (US)   II-70
      Bionime Corp. (Taiwan)  II-70
      B. Braun Melsungen AG (Germany)    II-71
      DexCom, Inc. (US)       II-71
      LifeScan, Inc. (US)     II-71
      Medtronic (US)II-72
      Nipro Diagnostics, Inc. (US)       II-72
      Nova Biomedical Corporation (USA)  II-73
      Roche Diagnostics Corp. (US)       II-73
      Terumo Europe NV (Belgium)         II-74

  8. GLOBAL MARKET PERSPECTIVE
      Table 12: World Recent Past, Current & Future  Analysis for
      Blood Glucose Monitoring Devices by Geographic Region - US,
      Canada, Japan, Europe,  Asia-Pacific (excluding Japan), Latin
      America and  Rest of World Markets Independently Analyzed
      with Annual Revenue Figures in US$ Million for  Years 2010
      through 2018 (includes corresponding Graph/Chart)       II-75

      Table 13: World Historic Review for Blood Glucose Monitoring
      Devices by Geographic Region - US,  Canada, Japan, Europe,
      Asia-Pacific (excluding  Japan), Latin America And Rest of
      World Markets Independently Analyzed with Annual Revenue
      Figures in US$ Million for Years 2004 through  2009 (includes
      corresponding Graph/Chart)         II-76

      Table 14: World 15-Year Perspective for Blood  Glucose
      Monitoring Devices by Geographic Region - Percentage Breakdown
      of Revenue in Dollars for  US, Canada, Japan, Europe,
      Asia-Pacific (excluding Japan), Latin America and Rest of
      World Markets  for Years 2004, 2013 & 2018 (includes
      corresponding Graph/Chart)         II-77

      Table 15: World Recent Past, Current & Future  Analysis for
      Blood Glucose Strips by Geographic  Region - US, Canada,
      Japan, Europe, Asia-Pacific (excluding Japan), Latin America
      and Rest of World  Markets Independently Analyzed with Annual
      Revenue Figures in US$ Million for Years 2010  through 2018
      (includes corresponding Graph/Chart)         II-78

      Table 16: World Historic Review for Blood Glucose  Strips by
      Geographic Region - US, Canada, Japan,  Europe, Asia-Pacific
      (excluding Japan), Latin America  and Rest of World Markets
      Independently Analyzed  with Annual Revenue Figures in US$
      Million for  Years 2004 through 2009 (includes corresponding
      Graph/Chart)  II-79

      Table 17: World 15-Year Perspective for Blood  Glucose Strips
      by Geographic Region - Percentage Breakdown of Revenue in
      Dollars for US, Canada,  Japan, Europe, Asia-Pacific
      (excluding Japan),  Latin America and Rest of World Markets
      for  Years 2004, 2013 & 2018 (includes corresponding
      Graph/Chart)  II-80

      Table 18: World Recent Past, Current & Future  Analysis for
      Blood Glucose Meters by Geographic  Region - US, Canada,
      Japan, Europe, Asia-Pacific (excluding Japan), Latin America
      and Rest of  World Markets Independently Analyzed with  Annual
      Revenue Figures in US$ Million for  Years 2010 through 2018
      (includes  corresponding Graph/Chart)        II-81

      Table 19: World Historic Review for Blood Glucose  Meters by
      Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
      (excluding Japan), Latin America  and Rest of World Markets
      Independently Analyzed  with Annual Revenue Figures in US$
      Million for  Years 2004 through 2009 (includes corresponding
      Graph/Chart)  II-82

      Table 20: World 15-Year Perspective for Blood  Glucose Meters
      by Geographic Region - Percentage Breakdown of Revenue in
      Dollars for US, Canada,  Japan, Europe, Asia-Pacific
      (excluding Japan),  Latin America and Rest of World Markets
      for  Years 2004, 2013 & 2018 (includes corresponding
      Graph/Chart)  II-83

      Table 21: World Recent Past, Current & Future  Analysis for
      Lancets by Geographic Region - US,  Canada, Japan, Europe,
      Asia-Pacific (excluding  Japan), Latin America and Rest of
      World Markets Independently Analyzed with Annual Revenue
      Figures in US$ Million for Years 2010 through  2018 (includes
      corresponding Graph/Chart)         II-84

      Table 22: World Historic Review for Lancets by  Geographic
      Region - US, Canada, Japan, Europe,  Asia-Pacific (excluding
      Japan), Latin America and  Rest of World Markets Independently
      Analyzed  with Annual Revenue Figures in US$ Million for
      Years 2004 through 2009 (includes corresponding Graph/Chart)      II-85

      Table 23: World 15-Year Perspective for Lancets by Geographic
      Region - Percentage Breakdown of  Revenue in Dollars for US,
      Canada, Japan, Europe,  Asia-Pacific (excluding Japan), Latin
      America and  Rest of World Markets for Years 2004, 2013 & 2018
      (includes corresponding Graph/Chart)         II-86


 III. MARKET

  1. THE UNITED STATES        III-1
      A.Market Analysis       III-1
        Current and Future Analysis      III-1
         Table 24: Prevalence of Diabetes Mellitus  in North America
         by Country: 2012     III-1

         Table 25: North America Incidence of  Type 1 Diabetes in
         Children: 2012  (includes corresponding Graph/Chart) III-2
        Diabetes in America: Key Facts and Figures III-2
        Self-Monitoring Meters and Strips Sales Dip  But Remain
         Buoyant Amid RecessionIII-3
        Market Growth Propellants        III-4
        Technologic Innovations Fuel US SMBG MarketIII-5
        Accuracy: A Major Cause of Concern Plaguing  SMBG Systems       III-5
        Emerging Technologies Threaten Conventional  Products III-5
        TGC Protocols: A Key Driver for Point of Care BGM Market        III-6
        Manufacturers Under Pressure to Discount  BGM Product Prices    III-6
         Table 26: North American Blood Glucose Strips Market
         (2012): Percentage Share Breakdown of Dollar Sales of SMBG
         Glucose Strips and POC Glucose Strips (includes
         corresponding  Graph/Chart)     III-6
        Drugstores Clearly Benefiting from the Diabetic  Care Category  III-7
        Competitive Landscape III-7
         Table 27: US Market for Glucose Test Kits (2012):
         Percentage Breakdown of Value Sales by Top  Brands
         (includes corresponding Graph/Chart)      III-8
        Challenges Facing Market Participants      III-8
         Snapshot of Leading BGM Meters  in the United States III-9
        Strategic Corporate Developments III-14
        Product Launches      III-20
        Select Major Players  III-22
      B.Market Analytics      III-26
        Table 28: US Recent Past, Current & Future  Analysis for
        Blood Glucose Monitoring Devices  by Product Segment - Blood
        Glucose Strips,  Blood Glucose Meters and Lancets Markets
        Independently Analyzed with Annual Revenue  Figures in US$
        Million for Years 2010 through  2018 (includes corresponding
        Graph/Chart)III-26

        Table 29: US Historic Review for Blood Glucose Monitoring
        Devices by Product Segment - Blood Glucose Strips, Blood
        Glucose Meters and  Lancets Markets Independently Analyzed
        with  Annual Revenue Figures in US$ Million for Years  2004
        through 2009 (includes corresponding Graph/Chart)     III-27

        Table 30: US 15-Year Perspective for Blood  Glucose
        Monitoring Devices by Product Segment - Percentage Breakdown
        of Revenue in Dollars for  Blood Glucose Strips, Blood
        Glucose Meters and Lancets Markets for Years 2004, 2013 &
        2018  (includes corresponding Graph/Chart) III-28

  2. CANADA         III-29
      A.Market Analysis       III-29
        Current and Future Analysis      III-29
        Strategic Corporate Developments III-29
        Product Launches      III-30
      B.Market Analytics      III-31
        Table 31: Canadian Recent Past, Current &  Future Analysis
        for Blood Glucose Monitoring  Devices by Product Segment -
        Blood Glucose  Strips, Blood Glucose Meters and Lancets
        Markets Independently Analyzed with Annual  Revenue Figures
        in US$ Million for Years  2010 through 2018 (includes
        corresponding Graph/Chart)       III-31

        Table 32: Canadian Historic Review for Blood  Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with  Annual Revenue Figures in US$
        Million for Years  2004 through 2009 (includes corresponding
        Graph/Chart)III-32

        Table 33: Canadian 15-Year Perspective for  Blood Glucose
        Monitoring Devices by Product  Segment - Percentage
        Breakdown of Revenue  in Dollars for Blood Glucose Strips,
        Blood  Glucose Meters and Lancets Markets for  Years 2004,
        2013 & 2018 (includes  corresponding Graph/Chart)     III-33

  3. JAPANIII-34
      A.Market Analysis       III-34
        Current and Future Analysis      III-34
        Japanese Medical Device Industry:  A Macro PerspectiveIII-34
        Product Launch        III-35
        Arkray, Inc. - A Key Player      III-35
      B.Market Analytics      III-36
        Table 34: Japanese Recent Past, Current & Future Analysis
        for Blood Glucose Monitoring Devices by Product Segment -
        Blood Glucose Strips, Blood  Glucose Meters and Lancets
        Markets Independently Analyzed with Annual Revenue Figures
        in  US$ Million for Years 2010 through 2018  (includes
        corresponding Graph/Chart)       III-36

        Table 35: Japanese Historic Review for Blood  Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with  Annual Revenue Figures in US$
        Million for Years  2004 through 2009 (includes corresponding
        Graph/Chart)III-37

        Table 36: Japanese 15-Year Perspective for Blood Glucose
        Monitoring Devices by Product Segment - Percentage Breakdown
        of Revenue in Dollars for  Blood Glucose Strips, Blood
        Glucose Meters and Lancets Markets for Years 2004, 2013 &
        2018  (includes corresponding Graph/Chart) III-38

  4. EUROPE         III-39
      A.Market Analysis       III-39
        Current and Future Scenario      III-39
        Prevalence of Diabetes: Aging Population  in Dominion III-39
         Table 37: Prevalence of Diabetes Mellitus in Europe: 2012      III-40
        Obesity: A Major Cause of Diabetes         III-41
        Diabetes Care in Europe: Riddled with Challenges      III-41
        St Vincent Declaration - A Step in the Right  Direction         III-42
      B.Market Analytics      III-43
        Table 38: European Recent Past, Current & Future Analysis
        for Blood Glucose Monitoring Devices by Geographic Region -
        France, Germany, UK, Italy,  Spain, Russia and Rest of
        Europe Markets Independently Analyzed with Annual Revenue
        Figures in US$ Million for Years 2010 through  2018
        (includes corresponding Graph/Chart)       III-43

        Table 39: European Historic Review for Blood  Glucose
        Monitoring Devices by Geographic Region - France, Germany,
        UK, Italy, Spain, Russia and  Rest of Europe Markets
        Independently Analyzed  with Annual Revenue Figures in US$
        Million for  Years 2004 through 2009 (includes corresponding
        Graph/Chart)III-44

        Table 40: European 15-Year Perspective for Blood Glucose
        Monitoring Devices by Geographic  Region - Percentage
        Breakdown of Revenue  in Dollars for France, Germany, UK,
        Italy, Spain,  Russia and Rest of Europe Markets for Years
        2004, 2013 & 2018 (includes corresponding Graph/Chart)III-45

        Table 41: European Recent Past, Current &  Future Analysis
        for Blood Glucose Monitoring  Devices by Product Segment -
        Blood Glucose  Strips, Blood Glucose Meters and Lancets
        Markets Independently Analyzed with Annual  Revenue Figures
        in US$ Million for Years  2010 through 2018 (includes
        corresponding Graph/Chart)       III-46

        Table 42: European Historic Review for Blood  Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with  Annual Revenue Figures in US$
        Million for Years  2004 through 2009 (includes corresponding
        Graph/Chart)III-47

        Table 43: European 15-Year Perspective for  Blood Glucose
        Monitoring Devices by Product  Segment - Percentage
        Breakdown of Revenue  in Dollars for Blood Glucose Strips,
        Blood  Glucose Meters and Lancets Markets for  Years 2004,
        2013 & 2018 (includes  corresponding Graph/Chart)     III-48

  4a. FRANCE        III-49
      A.Market Analysis       III-49
        Current and Future Analysis      III-49
        Product Launch        III-49
      B.Market Analytics      III-50
        Table 44: French Recent Past, Current & Future Analysis for
        Blood Glucose Monitoring Devices  by Product Segment - Blood
        Glucose Strips,  Blood Glucose Meters and Lancets Markets
        Independently Analyzed with Annual Revenue  Figures in US$
        Million for Years 2010 through  2018 (includes corresponding
        Graph/Chart)III-50

        Table 45: French Historic Review for Blood  Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with  Annual Revenue Figures in US$
        Million for  Years 2004 through 2009 (includes
        corresponding Graph/Chart)       III-51

        Table 46: French 15-Year Perspective for Blood Glucose
        Monitoring Devices by Product Segment - Percentage Breakdown
        of Revenue in Dollars  for Blood Glucose Strips, Blood
        Glucose Meters and Lancets Markets for Years 2004, 2013 &
        2018 (includes corresponding  Graph/Chart) III-52

  4b. GERMANY       III-53
      A.Market Analysis       III-53
        Current and Future Analysis      III-53
        Product Launch        III-53
        B. Braun Melsungen AG - A Key Player       III-53
      B.Market Analytics      III-54
        Table 47: German Recent Past, Current & Future Analysis for
        Blood Glucose Monitoring Devices  by Product Segment - Blood
        Glucose Strips,  Blood Glucose Meters and Lancets Markets
        Independently Analyzed with Annual Revenue  Figures in US$
        Million for Years 2010  through 2018 (includes corresponding
        Graph/Chart)III-54

        Table 48: German Historic Review for Blood  Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with  Annual Revenue Figures in US$
        Million for  Years 2004 through 2009 (includes
        corresponding Graph/Chart)       III-55

        Table 49: German 15-Year Perspective for Blood Glucose
        Monitoring Devices by Product Segment - Percentage Breakdown
        of Revenue in Dollars for  Blood Glucose Strips, Blood
        Glucose Meters and Lancets Markets for Years 2004, 2013 &
        2018  (includes corresponding Graph/Chart) III-56

  4c. ITALY         III-57
      A.Market Analysis       III-57
        Current and Future Analysis      III-57
      B.Market Analytics      III-57
        Table 50: Italian Recent Past, Current & Future  Analysis
        for Blood Glucose Monitoring Devices  by Product Segment -
        Blood Glucose Strips,  Blood Glucose Meters and Lancets
        Markets Independently Analyzed with Annual Revenue  Figures
        in US$ Million for Years 2010  through 2018 (includes
        corresponding  Graph/Chart)      III-57

        Table 51: Italian Historic Review for Blood Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with Annual  Revenue Figures in US$
        Million for Years 2004  through 2009 (includes corresponding
        Graph/Chart)III-58

        Table 52: Italian 15-Year Perspective for Blood Glucose
        Monitoring Devices by Product Segment - Percentage Breakdown
        of Revenue in Dollars  for Blood Glucose Strips, Blood
        Glucose Meters  and Lancets Markets for Years 2004, 2013 &
        2018 (includes corresponding  Graph/Chart) III-59

  4d. THE UNITED KINGDOM      III-60
      A.Market Analysis       III-60
        Current and Future Analysis      III-60
        Self-Monitoring Blood Glucose Gaining FavorIII-60
        Strategic Corporate Development  III-60
        Product Launches      III-60
      B.Market Analytics      III-62
        Table 53: UK Recent Past, Current & Future  Analysis for
        Blood Glucose Monitoring Devices  by Product Segment - Blood
        Glucose Strips,  Blood Glucose Meters and Lancets Markets
        Independently Analyzed with Annual Revenue  Figures in US$
        Million for Years 2010  through 2018 (includes corresponding
        Graph/Chart)III-62

        Table 54: UK Historic Review for Blood Glucose Monitoring
        Devices by Product Segment - Blood Glucose Strips, Blood
        Glucose Meters and  Lancets Markets Independently Analyzed
        with  Annual Revenue Figures in US$ Million for  Years 2004
        through 2009 (includes  corresponding Graph/Chart)    III-63

        Table 55: UK 15-Year Perspective for Blood  Glucose
        Monitoring Devices by Product  Segment - Percentage
        Breakdown of Revenue  in Dollars for Blood Glucose Strips,
        Blood  Glucose Meters and Lancets Markets for  Years 2004,
        2013 & 2018 (includes  corresponding Graph/Chart)     III-64

  4e. SPAIN         III-65
      A.Market Analysis       III-65
        Current and Future Analysis      III-65
      B.Market Analytics      III-65
        Table 56: Spanish Recent Past, Current & Future Analysis for
        Blood Glucose Monitoring Devices  by Product Segment - Blood
        Glucose Strips,  Blood Glucose Meters and Lancets Markets
        Independently Analyzed with Annual Revenue  Figures in US$
        Million for Years 2010 through  2018 (includes corresponding
        Graph/Chart)III-65

        Table 57: Spanish Historic Review for Blood  Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with  Annual Revenue Figures in US$
        Million for  Years 2004 through 2009 (includes
        corresponding Graph/Chart)       III-66

        Table 58: Spanish 15-Year Perspective for  Blood Glucose
        Monitoring Devices by Product  Segment - Percentage
        Breakdown of Revenue  in Dollars for Blood Glucose Strips,
        Blood  Glucose Meters and Lancets Markets for  Years 2004,
        2013 & 2018 (includes  corresponding Graph/Chart)     III-67

  4f. RUSSIA        III-68
      A.Market Analysis       III-68
        Current and Future Analysis      III-68
      B.Market Analytics      III-68
        Table 59: Russian Recent Past, Current &  Future Analysis
        for Blood Glucose Monitoring  Devices by Product Segment -
        Blood Glucose  Strips, Blood Glucose Meters and Lancets
        Markets Independently Analyzed with Annual  Revenue Figures
        in US$ Million for Years 2010  through 2018 (includes
        corresponding  Graph/Chart)      III-68

        Table 60: Russian Historic Review for Blood  Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with  Annual Revenue Figures in US$
        Million for  Years 2004 through 2009 (includes
        corresponding Graph/Chart)       III-69

        Table 61: Russian 15-Year Perspective for  Blood Glucose
        Monitoring Devices by Product  Segment - Percentage
        Breakdown of Revenue  in Dollars for Blood Glucose Strips,
        Blood  Glucose Meters and Lancets Markets for  Years 2004,
        2013 & 2018 (includes  corresponding Graph/Chart)     III-70

  4g. REST OF EUROPEIII-71
      A.Market Analysis       III-71
        Current and Future Analysis      III-71
        Strategic Corporate Developments III-71
        Terumo Europe NV - A Key Player  III-72
      B.Market Analytics      III-73
        Table 62: Rest of Europe Recent Past, Current &  Future
        Analysis for Blood Glucose Monitoring  Devices by Product
        Segment - Blood Glucose  Strips, Blood Glucose Meters and
        Lancets  Markets Independently Analyzed with Annual  Revenue
        Figures in US$ Million for Years 2010  through 2018
        (includes corresponding  Graph/Chart)      III-73

        Table 63: Rest of Europe Historic Review for  Blood Glucose
        Monitoring Devices by Product  Segment - Blood Glucose
        Strips, Blood Glucose  Meters and Lancets Markets
        Independently  Analyzed with Annual Revenue Figures in  US$
        Million for Years 2004 through 2009  (includes corresponding
        Graph/Chart)III-74

        Table 64: Rest of Europe 15-Year Perspective  for Blood
        Glucose Monitoring Devices by Product Segment - Percentage
        Breakdown of Revenue  in Dollars for Blood Glucose Strips,
        Blood  Glucose Meters and Lancets Markets for  Years 2004,
        2013 & 2018 (includes  corresponding Graph/Chart)     III-75

  5. ASIA-PACIFIC   III-76
      A.Market Analysis       III-76
        Current and Future Analysis      III-76
        Rising Diabetes Incidence in Asia-Pacific  III-76
         Table 65: Prevalence of Diabetes Mellitus in South East
         Asia: 2012 III-76

         Table 66: Prevalence of Diabetes Mellitus in Western Asia
         and Pacific Regions: 2012       III-77

         Table 67: Incidence of Type 1 Diabetes in Children by
         Select Countries in the Western Pacific: 2012 (includes
         corresponding Graph/Chart)      III-78
        High Growth on Cards for SMBG Devices      III-78
        Asia Suffers from Lack of Focus on Diabetes Care      III-78
         Healthcare Societies and Associations Spread  Awareness of
Diabetes  III-79
         Western Pacific Declaration on Diabetes   III-79
        Competitive Landscape III-79
        Distribution Dynamics III-80
        Strategic Corporate Development  III-80
      B.Market Analytics      III-81
        Table 68: Asia-Pacific Recent Past, Current &  Future
        Analysis for Blood Glucose Monitoring  Devices by Geographic
        Region - China, India,  and Rest of Asia-Pacific Markets
        Independently Analyzed with Annual Revenue Figures in  US$
        Million for Years 2010 through 2018  (includes corresponding
        Graph/Chart)III-81

        Table 69: Asia-Pacific Historic Review for Blood Glucose
        Monitoring Devices by Geographic Region - China, India, and
        Rest of Asia-Pacific Markets Independently Analyzed with
        Annual Revenue  Figures in US$ Million for Years 2004
        through  2009 (includes corresponding Graph/Chart)    III-82

        Table 70: Asia-Pacific 15-Year Perspective for  Blood
        Glucose Monitoring Devices by Geographic Region - Percentage
        Breakdown of Revenue  in Dollars for China, India, and Rest
        of  Asia-Pacific Markets for Years 2004, 2013 &  2018
        (includes corresponding Graph/Chart)       III-83

        Table 71: Asia-Pacific Recent Past, Current & Future
        Analysis for Blood Glucose Monitoring Devices by Product
        Segment - Blood Glucose Strips, Blood  Glucose Meters and
        Lancets Markets Independently Analyzed with Annual Revenue
        Figures in  US$ Million for Years 2010 through 2018
        (includes corresponding Graph/Chart)       III-84

        Table 72: Asia-Pacific Historic Review for Blood Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with  Annual Revenue Figures in US$
        Million for Years  2004 through 2009 (includes corresponding
        Graph/Chart)III-85

        Table 73: Asia-Pacific 15-Year Perspective for  Blood
        Glucose Monitoring Devices by Product  Segment - Percentage
        Breakdown of Revenue  in Dollars for Blood Glucose Strips,
        Blood  Glucose Meters and Lancets Markets for  Years 2004,
        2013 & 2018 (includes  corresponding Graph/Chart)     III-86

  5a. CHINA         III-87
      A.Market Analysis       III-87
        Current and Future Analysis      III-87
        China: An Untapped Goldmine      III-87
        Competition III-87
      B.Market Analytics      III-88
        Table 74: Chinese Recent Past, Current &  Future Analysis
        for Blood Glucose Monitoring  Devices by Product Segment -
        Blood Glucose  Strips, Blood Glucose Meters and Lancets
        Markets Independently Analyzed with Annual  Revenue Figures
        in US$ Million for Years  2010 through 2018 (includes
        corresponding  Graph/Chart)      III-88

        Table 75: Chinese Historic Review for Blood  Glucose
        Monitoring Devices by Product  Segment - Blood Glucose
        Strips, Blood  Glucose Meters and Lancets Markets
        Independently Analyzed with Annual  Revenue Figures in US$
        Million for  Years 2004 through 2009 (includes
        corresponding Graph/Chart)       III-89

        Table 76: Chinese 15-Year Perspective for  Blood Glucose
        Monitoring Devices by Product  Segment - Percentage
        Breakdown of Revenue  in Dollars for Blood Glucose Strips,
        Blood  Glucose Meters and Lancets Markets for  Years 2004,
        2013 & 2018 (includes  corresponding Graph/Chart)     III-90

  5b. INDIA         III-91
      A.Market Analysis       III-91
        Outlook     III-91
        Diabetic Epidemic Spurs Indian Market  for Blood Glucose
         Monitoring III-91
        Market Restraints     III-92
        Competition III-92
        Product Launches      III-93
      B.Market Analytics      III-94
        Table 77: Indian Recent Past, Current & Future  Analysis for
        Blood Glucose Monitoring Devices  by Product Segment - Blood
        Glucose Strips,  Blood Glucose Meters and Lancets Markets
        Independently Analyzed with Annual Revenue  Figures in US$
        Million for Years 2010  through 2018 (includes corresponding
        Graph/Chart)III-94

        Table 78: Indian Historic Review for Blood Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with Annual  Revenue Figures in US$
        Million for Years 2004  through 2009 (includes corresponding
        Graph/Chart)III-95

        Table 79: Indian 15-Year Perspective for  Blood Glucose
        Monitoring Devices by Product  Segment - Percentage
        Breakdown of Revenue  in Dollars for Blood Glucose Strips,
        Blood  Glucose Meters and Lancets Markets for  Years 2004,
        2013 & 2018 (includes  corresponding Graph/Chart)     III-96

  5c. REST OF ASIA-PACIFIC    III-97
      A.Market Analysis       III-97
        Current and Future Analysis      III-97
        A Review of Select Markets       III-97
         Australia: A Growing Market for SMBG      III-97
         Hong Kong  III-97
         Malaysia   III-98
         Taiwan     III-98
        Strategic Corporate Development  III-98
        Select Major Players  III-99
      B.Market Analytics      III-101
        Table 80: Rest of Asia-Pacific Recent Past,  Current &
        Future Analysis for Blood Glucose  Monitoring Devices by
        Product Segment - Blood Glucose Strips, Blood Glucose Meters
        and  Lancets Markets Independently Analyzed with  Annual
        Revenue Figures in US$ Million for  Years 2010 through 2018
        (includes  corresponding Graph/Chart)      III-101

        Table 81: Rest of Asia-Pacific Historic Review  for Blood
        Glucose Monitoring Devices by Product Segment - Blood
        Glucose Strips, Blood Glucose  Meters and Lancets Markets
        Independently  Analyzed with Annual Revenue Figures in  US$
        Million for Years 2004 through 2009  (includes corresponding
        Graph/Chart)III-102

        Table 82: Rest of Asia-Pacific 15-Year Perspective  for
        Blood Glucose Monitoring Devices by Product Segment -
        Percentage Breakdown of Revenue  in Dollars for Blood
        Glucose Strips, Blood Glucose Meters and Lancets Markets for
        Years 2004,  2013 & 2018 (includes corresponding
        Graph/Chart)III-103

  6. LATIN AMERICA  III-104
      A.Market Analysis       III-104
        Current and Future Analysis      III-104
         Table 83: Prevalence of Diabetes Mellitus in South &
         Central America (2012 & 2030): Breakdown by Country and Age
         Group (In 000 People & %)       III-104
        Diabetes Incidence    III-105
         Type-1 Diabetes      III-105
Table 84: South & Central America: Breakdown of Incidence
(per 100,000) of Type 1 Diabetes in Children by Select
Countries: 2012 (includes  corresponding Graph/Chart)         III-105
         Type-2 Diabetes      III-105
        National Diabetes Programs       III-106
      B.Market Analytics      III-106
        Table 85: Latin American Recent Past,  Current & Future
        Analysis for Blood Glucose  Monitoring Devices by Product
        Segment -  Blood Glucose Strips, Blood Glucose  Meters and
        Lancets Markets Independently  Analyzed with Annual Revenue
        Figures  in US$ Million for Years 2010 through  2018
        (includes corresponding  Graph/Chart)      III-106

        Table 86: Latin American Historic Review  for Blood Glucose
        Monitoring Devices by  Product Segment - Blood Glucose
        Strips,  Blood Glucose Meters and Lancets Markets
        Independently Analyzed with Annual  Revenue Figures in US$
        Million for Years  2004 through 2009 (includes corresponding
        Graph/Chart)III-107

        Table 87: Latin American 15-Year Perspective  for Blood
        Glucose Monitoring Devices by  Product Segment - Percentage
        Breakdown of  Revenue in Dollars for Blood Glucose  Strips,
        Blood Glucose Meters and Lancets  Markets for Years 2004,
        2013 & 2018  (includes corresponding Graph/Chart)     III-108

  7. REST OF WORLD  III-109
      A.Market Analysis       III-109
        Current and Future Analysis      III-109
        United Arab Emirates: Rising Diabetic Cases  to Propel
         Demand for Blood  Glucose MetersIII-109
        Key Statistics        III-109
         Table 88: Prevalence of Diabetes Mellitus in Middle East &
         North Africa: 2012   III-109

         Table 89: Eastern Mediterranean & Middle East: Breakdown of
         Incidence (per 100,000) of Type 1 Diabetes in Children by
         Select Countries: 2012 (includes  corresponding
         Graph/Chart)         III-110

         Table 90: Prevalence of Diabetes Mellitus in Africa: 2012      III-111

         Table 91: Incidence of Type 1 Diabetes in Children by
         Select African Countries: 2012 (includes corresponding
         Graph/Chart)         III-111
      B.Market Analytics      III-112
        Table 92: Rest of World Recent Past, Current &  Future
        Analysis for Blood Glucose Monitoring  Devices by Product
        Segment - Blood Glucose  Strips, Blood Glucose Meters and
        Lancets  Markets Independently Analyzed with Annual  Revenue
        Figures in US$ Million for Years  2010 through 2018
        (includes corresponding Graph/Chart)       III-112

        Table 93: Rest of World Historic Review for Blood Glucose
        Monitoring Devices by Product Segment - Blood Glucose
        Strips, Blood Glucose Meters and Lancets Markets
        Independently Analyzed with  Annual Revenue Figures in US$
        Million for Years  2004 through 2009 (includes corresponding
        Graph/Chart)III-113

        Table 94: Rest of World 15-Year Perspective for Blood
        Glucose Monitoring Devices by Product Segment - Percentage
        Breakdown of Revenue in Dollars for  Blood Glucose Strips,
        Blood Glucose Meters and Lancets Markets for Years 2004,
        2013 & 2018  (includes corresponding Graph/Chart)     III-114


 IV. COMPETITIVE LANDSCAPE

     Total Companies Profiled: 94 (including Divisions/Subsidiaries - 112 )

     The United States (54)
     Canada (6)
     Japan (7)
     Europe (22)
     - France (2)
     - Germany (4)
     - The United Kingdom (4)
     - Italy (1)
     - Rest of Europe (11)
     Asia-Pacific (Excluding Japan) (21)
     Middle East (2)

 

 

Additional Information:
This report is offered in PDF format via e-mail. Once downloaded, the PDF can’t be copied to another computer. The user is permitted to print one full copy of the report. Extra copies or licenses may be purchased at 10% of the list price.
Date of Publication:
Aug 2, 2013
File Format:
PDF via E-mail
Number of Pages:
299 Pages
Type the characters you see in the picture above.